Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Radiother. 2004 Oct;8(5):315-21.

[Biomodulation of transcriptional factor NF-kappa B by ionizing radiation].

[Article in French]

Author information

  • 1Département de radiothérapie, institut Jules-Bordet, 121, boulevard de Waterloo, 1000 Bruxelles, Belgique. nicolas_magne@hotmail.com

Abstract

NF-kappaB (Nuclear Factor-kappaB) was described for the first time in 1986 as a nuclear protein binding to the kappa immunoglobulin-light chain enhancer. Since then, NF-kappaB has emerged as an ubiquitous factor involved in the regulation of numerous important processes as diverse as immune and inflammatory responses, apoptosis and cell proliferation. These last two properties explain the implication of NF-kappaB in the tumorigenic process as well as the promise of a targeted therapeutic intervention. This review focuses on the current knowledge on NF-kappaB regulation and discusses the therapeutic potential of targeting NF-kappaB in cancer in particular during radiotherapy.

PMID:
15561597
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk